Connect
MJA
MJA

Rapid increase in intravenous iron therapy for women of reproductive age in Australia

Antonia W Shand and Natasha Nassar
Med J Aust 2021; 214 (6): . || doi: 10.5694/mja2.50979
Published online: 5 April 2021

In reply: We agree with Jayasuriya and colleagues that iron deficiency anaemia may be undertreated. Intravenous iron is recommended when rapid restoration of haemoglobin and iron stores is required, oral iron cannot be tolerated, or poor absorption is expected. The National Patient Blood Management Collaborative aims to prevent transfusion and its complications by optimising haemoglobin and iron stores.1 However, randomised trials do not show evidence for benefit of intravenous iron on all outcomes in all populations, including the need for blood transfusion. A recent large randomised trial found no evidence for benefit in giving intravenous iron preoperatively to patients with anaemia undergoing major abdominal surgery.2

  • Antonia W Shand1,2
  • Natasha Nassar3

  • 1 Children’s Hospital at Westmead, University of Sydney, Sydney, NSW
  • 2 Royal Hospital for Women, Sydney, NSW
  • 3 Menzies Centre for Health Policy, University of Sydney, Sydney, NSW


Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.